Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Recruiting now

Conditions studied: Wrinkle

In brief

A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.

Key facts

Study ID

NCT06385171

Run by

Global Aesthetics LLC

People needed

500

Starts

2024-05-22

Expected to finish

2027-01-05

Last updated by the study team

2024-05-24

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals of both genders.
• Must be in good physical health.
• Age between 20 and 65 years.
• Presence of both static (unchanging) and moderate dynamic (movement-induced) wrinkles on the forehead or glabellar region.
• Must possess the willingness and ability to understand and provide informed consent, as well as effectively communicate with study personnel.

You may not qualify if…

• Pregnant or breastfeeding female.
• Age below 20 or above 65 years.
• History of neuromuscular disorders, such as myasthenia gravis.
• History of facial surgery or presence of scars in the treatment area that could potentially interfere with or confound the results of the study.
• Recent treatment history within the past 6 months in the forehead or glabellar region, including:
• Ablative laser procedures.
• Radiofrequency device treatments.
• Ultrasound device treatments.
• Medium to deep chemical peels.
• Temporary soft tissue augmentation.
• Semi-permanent soft tissue augmentation within the past 2 years.
• Permanent soft tissue augmentation.
• Planned cosmetic procedures within the next 6 months in the same region.
• Intended use of tretinoin or retinoic acid within the next 6 months.
• Presence of active infection in the treated area, excluding mild acne.
• Allergy to cow's milk protein or albumin.
• Use of aminoglycoside medications.
• Current use of anticoagulation therapy.
• History of bleeding disorders.
• Diagnosis of mental illness.
• Inability to comprehend the study protocol or provide informed consent.

Where it is running

• Global Aesthetics LLC — Cisco, Texas, United States (enrolling)
• Global Aesthetics LLC — Lubbock, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.